Loading…

Hydrazinonieotinamide prolongs quantum dot circulation and reduces reticuloendothelial system clearance by suppressing opsonization and phagocyte engulfment

In this study, we investigated the effects of hydrazinonieotinamide (HYNIC)--a bifunctional crosslinker widely used to super(99m)Tc radiolabel protein and nanoparticles for imaging studies--on quantum dot opsonization, macrophage engulfment and in vivo kinetics. In streptavidin-coated quantum dots (...

Full description

Saved in:
Bibliographic Details
Published in:Nanotechnology 2012-12, Vol.23 (49), p.495102-1-9
Main Authors: Jung, K-H, Park, J W, Paik, J-Y, Lee, E J, Choe, Y S, Lee, K-H
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study, we investigated the effects of hydrazinonieotinamide (HYNIC)--a bifunctional crosslinker widely used to super(99m)Tc radiolabel protein and nanoparticles for imaging studies--on quantum dot opsonization, macrophage engulfment and in vivo kinetics. In streptavidin-coated quantum dots (SA-QDots), conjugation with HYNIC increased the net negative charge without affecting the zeta potential. Confocal microscopy and fluorescence-activated cell sorting showed HYNIC attachment to suppress SA-QDot engulfment by macrophages. Furthermore, HYNIC conjugation suppressed surface opsonization by serum protein including IgG. When intravenously injected into mice, HYNIC conjugation significantly prolonged the circulation of SA-QDots and reduced their hepatosplenic uptake. Diminished reticuloendothelial system clearance of SA-QDots and aminoPEG-QDots by HYNIC conjugation was also demonstrated by in vivo and ex vivo optical imaging. The effects of HYNIC on the opsonization, phagocytosis and in vivo kinetics of quantum dots were reversed by removal of the hydrazine component from HYNIC. Thus, surface functionalization with HYNIC can improve the in vivo kinetics of quantum dots by reducing phagocytosis via suppression of surface opsonization.
ISSN:0957-4484
DOI:10.1088/0957-4484/23/49/495102